The market has been high on Syros Pharmaceuticals Inc (SYRS) stock recently. SYRS gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.
Syros Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SYRS!
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With SYRS Stock Today?
Syros Pharmaceuticals Inc (SYRS) stock is trading at $1.07 as of 9:45 AM on Thursday, Apr 21, an increase of $0.05, or 4.75% from the previous closing price of $1.02. The stock has traded between $1.06 and $1.10 so far today. Volume today is low. So far 118,672 shares have traded compared to average volume of 760,578 shares.
To see InvestorsObserver's Sentiment Score for Syros Pharmaceuticals Inc click here.
More About Syros Pharmaceuticals Inc
Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States.
Click Here to get the full Stock Report for Syros Pharmaceuticals Inc stock.